These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 26619755

  • 1. Axonal degeneration in multiple sclerosis: defining therapeutic targets by identifying the causes of pathology.
    Lee JY, Biemond M, Petratos S.
    Neurodegener Dis Manag; 2015 Dec; 5(6):527-48. PubMed ID: 26619755
    [Abstract] [Full Text] [Related]

  • 2. Novel therapeutic targets for axonal degeneration in multiple sclerosis.
    Petratos S, Azari MF, Ozturk E, Papadopoulos R, Bernard CC.
    J Neuropathol Exp Neurol; 2010 Apr; 69(4):323-34. PubMed ID: 20448478
    [Abstract] [Full Text] [Related]

  • 3. Axonal degeneration in multiple sclerosis: is it time for neuroprotective strategies?
    Stys PK.
    Ann Neurol; 2004 May; 55(5):601-3. PubMed ID: 15122698
    [No Abstract] [Full Text] [Related]

  • 4. [Neuronal injury in multiple sclerosis].
    Correale J, Meli F, Ysrraelit C.
    Medicina (B Aires); 2006 May; 66(5):472-85. PubMed ID: 17137182
    [Abstract] [Full Text] [Related]

  • 5. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.
    Lassmann H.
    Exp Neurol; 2010 Sep; 225(1):2-8. PubMed ID: 19840788
    [Abstract] [Full Text] [Related]

  • 6. How does Nogo-A signalling influence mitochondrial function during multiple sclerosis pathogenesis?
    Nheu D, Petratos S.
    Neurosci Biobehav Rev; 2024 Aug; 163():105767. PubMed ID: 38885889
    [Abstract] [Full Text] [Related]

  • 7. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
    Grigoriadis N, Ben-Hur T, Karussis D, Milonas I.
    Clin Neurol Neurosurg; 2004 Jun; 106(3):211-7. PubMed ID: 15177770
    [Abstract] [Full Text] [Related]

  • 8. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
    Herrero-Herranz E, Pardo LA, Gold R, Linker RA.
    Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527
    [Abstract] [Full Text] [Related]

  • 9. Remyelinating strategies in multiple sclerosis.
    Luessi F, Kuhlmann T, Zipp F.
    Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade.
    Van der Walt A, Butzkueven H, Kolbe S, Marriott M, Alexandrou E, Gresle M, Egan G, Kilpatrick T.
    Pharmacol Ther; 2010 Apr; 126(1):82-93. PubMed ID: 20122960
    [Abstract] [Full Text] [Related]

  • 11. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease.
    Bjartmar C, Wujek JR, Trapp BD.
    J Neurol Sci; 2003 Feb 15; 206(2):165-71. PubMed ID: 12559505
    [Abstract] [Full Text] [Related]

  • 12. Multiple sclerosis: does Nogo play a role?
    Lee JY, Petratos S.
    Neuroscientist; 2013 Aug 15; 19(4):394-408. PubMed ID: 23423307
    [Abstract] [Full Text] [Related]

  • 13. Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?
    Kim MJ, Kang JH, Theotokis P, Grigoriadis N, Petratos S.
    Cells; 2018 Dec 20; 8(1):. PubMed ID: 30577457
    [Abstract] [Full Text] [Related]

  • 14. [Axonal degeneration in the pathogenesis of multiple sclerosis].
    Mirowska D, Członkowska A.
    Neurol Neurochir Pol; 2002 Dec 20; 36(4):777-89. PubMed ID: 12418141
    [Abstract] [Full Text] [Related]

  • 15. The role of mitochondria in axonal degeneration and tissue repair in MS.
    van Horssen J, Witte ME, Ciccarelli O.
    Mult Scler; 2012 Aug 20; 18(8):1058-67. PubMed ID: 22723572
    [Abstract] [Full Text] [Related]

  • 16. Axonal and neuronal degeneration in myelin diseases.
    Ohno N, Ikenaka K.
    Neurosci Res; 2019 Feb 20; 139():48-57. PubMed ID: 30179642
    [Abstract] [Full Text] [Related]

  • 17. Longitudinal MR spectroscopy of neurodegeneration in multiple sclerosis with diffusion of the intra-axonal constituent N-acetylaspartate.
    Wood ET, Ercan E, Sati P, Cortese ICM, Ronen I, Reich DS.
    Neuroimage Clin; 2017 Feb 20; 15():780-788. PubMed ID: 28702353
    [Abstract] [Full Text] [Related]

  • 18. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS, Stormanns ER, Bader J, Arnhold S, Addicks K, Kuerten S.
    Clin Immunol; 2013 Oct 20; 149(1):32-45. PubMed ID: 23899992
    [Abstract] [Full Text] [Related]

  • 19. Changes at the nodal and perinodal axonal domains: a basis for multiple sclerosis pathology?
    Desmazières A, Sol-Foulon N, Lubetzki C.
    Mult Scler; 2012 Feb 20; 18(2):133-7. PubMed ID: 22217583
    [Abstract] [Full Text] [Related]

  • 20. Neuronal injury in chronic CNS inflammation.
    Zindler E, Zipp F.
    Best Pract Res Clin Anaesthesiol; 2010 Dec 20; 24(4):551-62. PubMed ID: 21619866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.